Digital Sponsored 4 Questions pharma leaders can’t skip before letting AI act Nataliya Andreychuk explains what teams must do before letting AI act on their behalf, and how that groundwork becomes a competitive advantage.
Digital Sponsored The content velocity trap: Why producing more is making your... Viseven explores how to fix the broken upstream engagement strategy process without losing even more time, resources, and effort in the process.
Market Access Is AI the missing link in fixing MLR – or the reason it brea... Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n
Digital Sponsored Accelerating the content lifecycle: A 7-step guide for AI in... By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.
Digital Sponsored Is AI the missing link in fixing the broken MLR process? Marketing teams often wait up to two months for medical legal regulatory (MLR) feedback.
Digital Veeva Commercial Summit: On AI, content, and MLR Review with... At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial Content Strategy, Europe.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.